KindlyMD (NASDAQ:NAKA – Get Free Report) and Cannae (NYSE:CNNE – Get Free Report) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, risk, profitability, analyst recommendations and dividends.
Analyst Ratings
This is a summary of current recommendations and price targets for KindlyMD and Cannae, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| KindlyMD | 1 | 0 | 3 | 0 | 2.50 |
| Cannae | 1 | 0 | 2 | 0 | 2.33 |
KindlyMD currently has a consensus target price of $20.00, suggesting a potential upside of 160.08%. Cannae has a consensus target price of $17.00, suggesting a potential upside of 3.41%. Given KindlyMD’s stronger consensus rating and higher probable upside, equities analysts clearly believe KindlyMD is more favorable than Cannae.
Profitability
This table compares KindlyMD and Cannae’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| KindlyMD | -1,067.93% | -63.45% | -41.04% |
| Cannae | -38.18% | -14.10% | -10.60% |
Insider & Institutional Ownership
88.1% of Cannae shares are owned by institutional investors. 24.5% of KindlyMD shares are owned by insiders. Comparatively, 10.9% of Cannae shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Valuation & Earnings
This table compares KindlyMD and Cannae”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| KindlyMD | $1.82 million | 77.53 | -$52.23 million | ($35.85) | -0.21 |
| Cannae | $423.60 million | 1.68 | -$513.20 million | ($3.02) | -5.44 |
KindlyMD has higher earnings, but lower revenue than Cannae. Cannae is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
KindlyMD has a beta of 15.82, suggesting that its share price is 1,482% more volatile than the S&P 500. Comparatively, Cannae has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500.
Summary
KindlyMD beats Cannae on 7 of the 13 factors compared between the two stocks.
About KindlyMD
Kindly MD, Inc. (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. Through its focus on an embedded model of prescriber and therapist teams, KindlyMD develops patient-specific care programs with a specific mission to reduce opioid use in the patient population while successfully treating patients with effective and evidence-based non-opioid alternatives in close conjunction with behavioral therapy. Beyond its treatment of patients, KindlyMD collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The Company captures all relevant datapoints to assist and appropriately treat each individual patient. This also results in valuable data for the Company and the Company’s investors. We strive to become a source for evidence-based guidelines, data, treatment models, and education in the fight against the opioid crisis in America. Business Revenue Streams We currently earn revenue through (i) patient care services related to medical evaluation and treatment and (ii) product retail sales. Our forecasted plan is to operate across various revenue streams: (i) medical evaluation and treatment visits reimbursed by Medicare, Medicaid, and commercial insurance payers as well as self-pay services, (ii) data collection and research, (iii) education partnerships, (iv) service affiliate agreements, and (v) retail sales. Our principal executive offices are located at 5097 S 900 E, Suite 100 Salt Lake City, UT.
About Cannae
Cannae Holdings, Inc. is a principal investment firm. The firm primarily invests in restaurants, technology enabled healthcare services, financial services and more. It takes both minority and majority stakes. Cannae Holdings, Inc. was founded in 2014 and is based in Las Vegas, Nevada.
Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.
